We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Oral Contraceptive Use Linked to Glaucoma Risk

By HospiMedica International staff writers
Posted on 28 Nov 2013
Women who took oral contraceptives for three or more years are twice as likely to suffer from glaucoma, according to a new study.

Researchers at University of California, San Francisco (UCSF; USA), Duke University (Durham, NC, USA) and Third Affiliated Hospital of Nanchang University (China) utilized 2005-2008 data from the National Health and Nutrition Examination Survey (NHANES), administered by the US Centers for Disease Control (CDC; Atlanta, GA, USA). In all, the study included 3,406 female participants aged 40 years or older from across the United States who completed a vision and reproductive health questionnaire and underwent eye exams.

The results showed that females who had used oral contraceptives—no matter what kind—for longer than three years were 2.05 times more likely to report that they have been diagnosed with glaucoma. The researchers added that although there is no reference to the causative effect of oral contraceptives on the development of glaucoma, long-term use of oral contraceptives appears to be potential risk factor for glaucoma, and may be considered as part of the risk profile, along with other risk factors such as ethnicity, family history of glaucoma, history of increased eye pressure, or existing visual field defects. The study was presented at the annual meeting of the American Academy of Ophthalmology, held during November 2013 in New Orleans (LA, USA).

“Previous studies in the field have shown that estrogen may play a significant role in the pathogenesis of glaucoma,” said lead author and study presenter Shan Lin, MD, a professor of clinical ophthalmology at UCSF. “At this point, women who have taken oral contraceptives for three or more years should be screened for glaucoma and followed closely by an ophthalmologist, especially if they have any other existing risk factors.”

Cells in the retina are known to have estrogen receptors, which indicate the hormone could have a protective effect. As a result, it is reasonable to assume that contraceptives that suppress cyclical spikes in women's estrogen levels could affect the eyes.

Related Links:

University of California, San Francisco
Duke University
Nanchang University



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
New
Portable X-ray Unit
AJEX140H
New
Clinical Display
C14S

Latest Patient Care News

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization